Vicente Anido, Jr.
2015
In 2015, Vicente Anido, Jr. earned a total compensation of $3.9M as Chief Executive Officer & Chairman of the Board at Aerie Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
| Bonus | $366,010 |
|---|---|
| Option Awards | $2,412,028 |
| Salary | $530,450 |
| Stock Awards | $621,930 |
| Total | $3,930,418 |
Anido received $2.4M in option awards, accounting for 61% of the total pay in 2015.
Anido also received $366K in bonus, $530.5K in salary and $621.9K in stock awards.
Rankings
In 2015, Vicente Anido, Jr.'s compensation ranked 2,232nd out of 13,638 executives tracked by ExecPay. In other words, Anido earned more than 83.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,232 out of 13,638 | 84th |
Division Manufacturing | 800 out of 5,187 | 85th |
Major group Chemicals And Allied Products | 285 out of 1,857 | 85th |
Industry group Drugs | 224 out of 1,531 | 85th |
Industry Biological Products, Except Diagnostic Substances | 39 out of 260 | 85th |
Source: SEC filing on April 27, 2017.
Anido's colleagues
We found two more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2015.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019